Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome

Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome

(2011) P. B. Jeppesen et al.   GUT

The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients

(2011) Lasse Bremholm et al.   REGULATORY PEPTIDES

ErbB Activity Links the Glucagon-Like Peptide-2 Receptor to Refeeding-Induced Adaptation in the Murine Small Bowel

(2010) Jasmine Bahrami et al.   GASTROENTEROLOGY

Four-month treatment with GLP-2 significantly increases hip BMD

(2009) Dennis B. Henriksen et al.   BONE

Some new insights in intestinal failure-associated liver disease

(2009) Olivier Goulet et al.   Current Opinion in Organ Transplantation

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

(2009) P. D. Cani et al.   GUT

Population Pharmacokinetics of Teduglutide Following Repeated Subcutanenous Administrations in Healthy Participants and in Patients With Short Bowel Syndrome and Crohn's Disease

(2009) Jean-Francois Marier et al.   JOURNAL OF CLINICAL PHARMACOLOGY

GLP-2 Administration Results in Increased Proliferation but Paradoxically an Adverse Outcome in a Juvenile Piglet Model of Short Bowel Syndrome

(2009) Prue M Pereira-Fantini et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Interleukin-10-independent anti-inflammatory actions of glucagon-like peptide 2

(2008) Catherine P. A. Ivory et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Tube Feeding Improves Intestinal Absorption in Short Bowel Syndrome Patients

(2008) Francisca Joly et al.   GASTROENTEROLOGY

Pharmacokinetics, Safety, and Tolerability of Teduglutide, a Glucagon-Like Peptide-2 (GLP-2) Analog, Following Multiple Ascending Subcutaneous Administrations in Healthy Subjects

(2008) Jean-Francois Marier et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Glucagon-like peptide-2 increases mesenteric blood flow in humans

(2008) Lasse Bremholm et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY